THERAVANCE BIOPHARMA INC (TBPH) Stock Cash Flow
NASDAQ:TBPH - Nasdaq - KYG8807B1068 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -58.33M | -56.42M | -55.19M | -92.82M | -199.43M | |||
| Depreciation Amortization | 5.97M | 6.12M | 6.15M | 3.72M | 5.91M | |||
| Income Taxes - Deferred | -8.91M | -7.57M | 3.21M | N/A | N/A | |||
| Change In Working Capital | 68.17M | 20.36M | -8.34M | 42.35M | -39.58M | |||
| Interest Paid | N/A | 0.00 | 0.00 | 22.24M | 39.03M | |||
| Taxes Paid | 96.00K | 109.00K | 24.00K | 117.97M | 4.09M | |||
| Other non cash items | 25.63M | 25.98M | 27.18M | -140.23M | 25.24M | |||
| OPERATING CASH FLOW | 32.53M | -11.54M | -27.00M | -186.99M | -207.86M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -332.00K | -2.49M | -570.00K | -3.41M | |||
| Other Investing Activity | 26.13M | 12.62M | -30.21M | 1.15B | 127.90M | |||
| INVESTING CASH FLOW | 25.89M | 12.28M | -32.70M | 1.15B | 124.49M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | -631.60M | -10.73M | |||
| Stock Issued/Repurchased | -2.14M | -3.00M | -199.55M | -132.28M | 99.12M | |||
| Other Financing Activity | N/A | 508.00K | 618.00K | 5.08M | 3.47M | |||
| FINANCING CASH FLOW | -1.64M | -2.50M | -198.93M | -758.81M | 91.86M | |||
| CHANGE IN CASH | 56.78M | -1.75M | -258.63M | 208.21M | 8.49M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 32.53M | -11.54M | -27.00M | -186.99M | -207.86M | |||
| Capital Expenditure | N/A | -332.00K | -2.49M | -570.00K | -3.41M | |||
| FREE CASH FLOW | 32.28M | -11.87M | -29.48M | -187.56M | -211.27M | |||
All data in USD